We previously found that CD4
1 CD25
1

FoxP3
1 regulatory T cells (Tregs) expand in response to Mycobacterium tuberculosis infection in individuals who are healthy tuberculin reactors, but not in tuberculin-negative individuals. We also found that the M. tuberculosis mannose-capped lipoarabinomannan and prostaglandin E2 produced by monocytes are involved in Treg expansion. In this study, we found that Tregs expanded from CD4
1 CCR4 1 cells but not from CCR4 2 cells. However, introduction of CCR4 small interfering RNA (siRNA) into CD4
1 cells only marginally reduced expansion of Tregs. Using siRNA and neutralizing antibodies, we found that expansion of Tregs by M. tuberculosis required expression of programmed death1 (PD-1) and expression of the signaling molecule, cytokine inducible SH2-containing protein (CISH). Anti-PD-1 siRNA inhibited expression of CISH by expanded Tregs. M. tuberculosis-expanded Tregs produced transforming growth factor b and interleukin 10 and reduced the frequency of interferon c-producing autologous CD8 
cells. We conclude that M. tuberculosis infection induces development of Tregs from CCR4
1 cells through a process that depends on PD-1and CISH.
Regulatory CD4
1 T cells (Tregs) that express CD25 and FoxP3 [1] constitute 5%-10% of CD4 1 T cells in mice and humans and are essential to maintain peripheral tolerance and homeostasis. Several studies have demonstrated that Tregs can prevent autoimmunity, inhibit transplant graft rejection, suppress the immune response to tumors, and play a role in infectious diseases [1] [2] [3] [4] [5] .
In Mycobacterium tuberculosis infection, Tregs proliferate and accumulate at sites of infection [6, 7] and prevent bacillary clearance in mice [8] . In patients with tuberculosis, T cell production of interferon c (IFN-c) in response to mycobacterial antigen is reduced compared with that in healthy tuberculin reactors [9] . Patients with tuberculosis have increased numbers of Tregs that inhibit IFN-c production by bacille Calmette-Guérin-stimulated CD4
1
CD25
2 T cells, and depletion of Tregs enhances M. tuberculosis-induced IFN-c production by peripheral blood mononuclear cells (PBMCs), suggesting that Tregs inhibit effective immunity [10, 11] . Tregs suppress antigen-specific human memory cdT cell responses to M. tuberculosis [12] . We found that Tregs expand in response to M. tuberculosis in healthy tuberculin reactors and that expanded Tregs inhibit IFN-c production by T cells [11] , suggesting that Tregs may limit tissue inflammation and destruction. However, the cellular mechanisms that mediate expansion of M. tuberculosisinduced Tregs are unknown.
In the present study, we found that M. tuberculosis infection induces development of Tregs from CCR4 1 cells, and that this process depends on programmed death 1 (PD-1) and cytokine inducible SH2-containing protein (CISH).
MATERIALS AND METHODS
Patient Population
After obtaining informed consent, blood was obtained from 20 healthy persons with positive QuantiFERON-TB Gold test results, which is indicative of latent tuberculosis infection. All donors were 18-65 years old; did not have a history of tuberculosis, AIDS, or human immunodeficiency virus (HIV) infection; and were not receiving therapy with immunosuppressive drugs. All studies were approved by the institutional review board of the University of Texas Health Science Center at Tyler.
Antibodies and Other Reagents
For flow cytometry, we used fluorescein isothiocyanate (FITC) anti-CD4, allophycocyanin (APC) anti-CD25, phycoerythrin (PE) anti-FoxP3, PE-Cy5 anti-FoxP3 (all from eBioscience); and FITC anti-CD14, FITC anti-CD8, PE anti-PD1, and PE anti-CD127 (all from BD Biosciences). For neutralization, we used monoclonal antibodies to PD-1 and interleukin 12Rb2 (IL-12Rb2; both at a concentration of 10 lg/mL; R&D systems); and inducible T cell costimulator molecule (ICOS) and cytotoxic T lymphocyte associated antigen 4 (CTLA-4; both at a concentration of 10 lg/mL; eBioscience). We obtained c-irradiated M. tuberculosis H37Rv J. Belisle (Colorado State University, Fort Collins, CO).
Isolation of Cell Subpopulations
PBMCs were isolated by differential centrifugation over FicollPaque (Amersham Pharmacia Biotech). CD14
1 cells were isolated by positive immunomagnetic selection (Miltenyi Biotec) and were .95% CD14 
CD25
2 cells were isolated from PBMCs by use of the Treg isolation kit (Miltenyi Biotec), as described elsewhere [11] . To isolate PD-1 1 cells, CD14 
Western Blot Analysis
Protein was extracted from M. tuberculosis-expanded Tregs and quantified by the bicinchoninic acid method (Pierce). Ten micrograms from each sample was separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis, transferred to nitrocellulose, and probed with antibodies to CISH, b-actin, or glyceraldehyde 3-phosphate dehydrogenase (all from Santa Cruz Biotechnology). After washing, the membranes were incubated with horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology), and binding was detected by electrochemiluminescence (GE Healthcare).
Statistical Analysis
Results are given as the mean (6 SE). Comparisons between groups were performed with a paired or unpaired t test, as appropriate.
RESULTS
Microarray Analysis of Expanded Tregs
To identify the intracellular signaling molecules that mediate expansion of Tregs from M. tuberculosis-stimulated CD4 1 cells, we compared gene expression profiles of expanded Tregs and CD4 1 non-Tregs, using microarray analysis (supplemental data Table S1 ). CD4 1 cells and autologous monocytes from 2 healthy tuberculin reactors were cultured with c-irradiated M. tuberculosis H37Rv. Tregs express low levels of the interleukin 7 receptor, CD127 [13, 14] . After 3 d, we isolated CD4 ). Total RNA was obtained, and microarray analysis was performed for 1,200 genes that are involved in immune responses. In the samples from both donors, messenger RNA (mRNA) expression for 49 genes was .2-fold higher in Tregs than in non-Tregs (supplemental data Table S1 ). Of these genes, we selected IL-12Rb2, chemokine receptor CCR4, ICOS, CTLA-4, and the intracellular signaling molecules, CISH and CREM, for further study. CCR4 antagonists block accumulation of human Tregs during administration of a vaccine encoding M. tuberculosis antigens [15] . IL-12Rb2 promotes development of Tregs [16] . ICOS and CTLA-4 are expressed by Tregs in different experimental systems [17, 18] , CISH is associated with Th2 responses [19] , and CREM is linked to reduced T cell activation in systemic lupus erythematosus [20] . We first studied expansion of Tregs from CD4 (Figure 3 ). We used siRNA to determine whether CISH was necessary for expansion of Tregs. CISH siRNA significantly inhibited expression of CISH protein, as measured by Western blot, and CREM siRNA inhibited CREM mRNA expression, as determined by real-time polymerase chain reaction (data not shown). CD4 
PD-1 Regulates CISH Expression
The above findings suggest that PD-1 and the intracellular signaling protein CISH mediate Treg expansion by M. tuberculosis. To delineate the relationship between these molecules, we asked whether blocking PD-1 affects CISH expression. We cultured CD4
1
CD25
2 cells and autologous monocytes from PBMCs of healthy tuberculin reactors, with c-irradiated M. tuberculosis, in the presence or absence of antibodies to PD-1 (10 lg/mL) and isotype control antibodies for 4 days. Western blot analysis of cellular extracts showed that CISH expression was reduced by anti-PD-1 but not by isotype control antibodies ( Figure 5 ). Tregs, we measured their capacity to produce immunosuppressive cytokines and to inhibit IFN-c production. We cultured CD4 Figure 6B ).
These results demonstrate that the cells designated as M. tuberculosis-induced Tregs in our experimental system produce immunosuppressive cytokines and can inhibit T cell cytokine production.
DISCUSSION
Recent animal and human studies found that Tregs expand in response to M. tuberculosis and inhibit effective immunity [6] [7] [8] [9] [10] [11] [12] , but limited published information is available on the cellular mechanisms that mediate M. tuberculosis-induced Treg expansion. We found that M. tuberculosis induces some CD4
1
CCR4
1 cells to express FoxP3, but this process did not require CCR4. Furthermore, when CD4 1 cells were exposed to M. tuberculosis-activated mononuclear phagocytes, PD-1 upregulated the expression of CISH and facilitated expansion of Tregs. Our study provides the first (to our knowledge) evidence that PD-1 and CISH contribute to Treg development during infection.
Chemokine receptors are critical for T cells to home to sites of infection and inflammation. Tregs expressing CCR4 are recruited to the site of disease in patients infected with the fungus Paracoccidiodes braziliensis [21] . Furthermore, CCR4 antagonists block accumulation of human Tregs during administration of a vaccine encoding M. tuberculosis antigens [15] . Our unpublished data indicate that M. tuberculosis stimulates monocytes to express the CCR4 ligands, CCL22 and CCL17, suggesting that CD4 
1 Tregs migrate to the site of mycobacterial infection. We demonstrated that M. tuberculosisinduced Tregs expanded more effectively from CD4 cells expressing CCR4. However, CCR4 was not essential for Treg expansion, which was only marginally affected by CCR4 siRNA. The sum of these data suggest that CCR4 may be important for migration of Tregs to inflammatory sites but that expansion of Tregs depends on PD-1, rather than CCR4. Multiple mechanisms have been identified for induction of Tregs in different experimental systems. Antigen-presenting cells, such as dendritic cells, are essential for expansion of Tregs through costimulatory molecules, such as B7 and ICOS [22, 23] , and soluble factors, including interleukin 15, TGF-b, and prostaglandin E2 [24] [25] [26] . Cell surface receptors, such as Tolllike receptor 2, also control expansion and function of Tregs, thereby suppressing immunity to Candida albicans [27] .
Substantial evidence indicates that interactions between PD-1 and its ligands, programmed death ligand 1 (PDL-1) and programmed death ligand 2, negatively regulate T cell proliferation and cytokine production [28, 29] . Blocking these interactions enhances graft rejection and immunity to intracellular pathogens, whereas PD-1 deficiency facilitates the development of autoimmunity [28] . However, limited information is available on the relationship between PD-1 and Tregs. Some investigators reported that PDL-1-negative dendritic cells failed to support induction of adaptive Tregs [30, 31] , suggesting that PD-1/PDL-1 signaling is required for Treg expansion. In contrast, other investigators found that PD-1 limited proliferation of hepatic Tregs in patients with chronic hepatitis C virus infection by inhibiting interleukin 2-driven phosphorylation of signal transducer and activator of transcription 5 (STAT5) [32] . We found that blocking PD-1, but not ICOS or CTLA-4, markedly inhibits Treg expansion in response to M. tuberculosis (Figure 2 ). This suggests that interactions between PD-1 on activated T cells and its ligands on M. tuberculosis-infected monocytes are essential for expansion of Tregs.
Up-regulation of FoxP3 expression in Tregs is mediated through several signaling pathways, including p38 MAP kinase [33] , linker for activation of T cells [34] , and Notch1 [35, 36] . We provide evidence that an additional signaling molecule, CISH, contributes to expansion of Tregs in response to a microbial pathogen. CISH is a member of the family of suppressors of cytokine signaling (SOCS) proteins, which inhibit cytokine signaling by competing with Janus kinase and STAT proteins for binding to cytokine receptors [37] . SOCS-1 ameliorates colitis in mice and favors Treg development [38] . However, the role of CISH in the expansion of Tregs is unknown. We found that M. tuberculosis-expanded Tregs have increased expression of CISH and that CISH siRNA inhibits Treg expansion. We also found that PD-1 contributes to expansion of Tregs and that blocking PD-1 inhibits CISH expression. The cytoplasmic tail of PD-1 contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) and an immunoreceptor tyrosine-based switch motif (ITSM), which can act as docking sites for Src homology 2 domain containing protein tyrosine phosphatase 2 (SHP-2) and SHP-1. SOCS proteins, including CISH, have a conserved modular structure with pre-Src homology 2 (SH2) and SH2 domains, and SOCS3 binds to ITIM-like motifs via SH2 [39] . Our results and published information suggest that CISH may bind to the ITIM or ITSM of the PD-1 cytoplasmic tail, initiating downstream signaling that up-regulates FoxP3 expression and mediates expansion of Tregs. A potential pathway for this effect is through binding of CISH to protein kinase Cu [19, 40] , which enhances FoxP3 expression of natural Tregs by activating nuclear factor of activated T cells [41] , which binds to the FoxP3 promoter and up-regulates gene expression [42] [43] [44] [45] [46] .
Previous studies have found that Tregs are selectively enriched in the blood of patients with tuberculosis and at the sites of infection [11, 47, 48] , but their role in disease pathogenesis remains controversial. Elegant experiments in mice suggest that Tregs inhibit immune responses to M. tuberculosis by delaying trafficking of effector T cells to the site of infection [49] , whereas studies in primates indicate that Treg expansion occurs in response to inflammation during early tuberculosis [50] , suggesting that they contribute to limiting tissue destruction. Using human cells cultured with M. tuberculosis in vitro, we previously showed that Tregs expand from CD4 1 cells from healthy tuberculin reactors, but not from those from tuberculin-negative donors [11] , indicating that Treg expansion is antigen-specific in the setting of exposure to mycobacterial antigen. A limitation of our system is that cells are cultured for a relatively short period in vitro with high antigen concentrations, which may not reflect conditions in the lung in vivo. Nevertheless, our present study provides insight into potential cellular mechanisms by which Tregs may expand in response to M. tuberculosis and should spur additional work to determine whether PD-1 and CISH contribute to Treg expansion from CCR4 1 T cells in vivo in patients with tuberculosis. 
